Interlace Trial
Induction chemotherapy followed by chemoradiotherapy significantly improves both progression-free survival and overall survival in patients with locally advanced cervical cancer compared to chemoradiotherapy alone.
Shitanshu Uppal
Publications Update # 77
Living Room - Podcast Episode from Love+Radio, Keynote B21 trial and a video discussion of the trial and Compassion 16 trial in cervical cancer
COMPASSION 16
Cadonilimab potentially offers better PFS than pembrolizumab and atezolizumab therapies in recurrent advanced metastatic cervical cancer
Publications Update # 76
Focused Topic: Gestational Trophoblastic Neoplasia.
Gestational Trophoblastic Disease: Part 1
Publications Update # 75
Anthropocene Reviewed Podcast, tryanny of non-inferiority trials and a mini-tutorial on non-inferiority trials, GY-005 results, ENGOT-OV41 ANITA trial
Mucinous Ovarian Carcinoma
GOG 241: Phase III Randomized Trial in Patients with Mucinous Epithelial Ovarian Cancer
Neither oxaliplatin-capecitabine nor bevacizumab significantly improved OS or PFS compared to paclitaxel-carboplatin in advanced-stage mucinous ovarian cancer.
Vulvar Melanoma
Publications Update # 74
FIGO 2023 staging system for endometrial cancer - a deep dive.